About Covalon
Covalon is a publicly listed company based in Toronto (Canada) founded in 2003 by Val DiTizio. It develops technologies, products and services to address the needs of medical device companies and healthcare providers. Covalon has completed 1 acquisition, including AquaGuard. Its chief executive, as recorded, is Brent Ashton. Covalon offers products and services including CovaClear IV, IV Clear, VALGuard, SurgiClear, and ColActive Plus. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Diversified.
Company details
Covalon Technologies was founded in 2003 in Toronto, Canada, within the medical technology sector. Advanced technologies, products, and services are created to meet requirements of medical device companies and healthcare providers. Collaboration occurs with manufacturers, leveraging a patent portfolio and in-house laboratory facilities to deliver specialized expertise and support. Operations focus on innovation tailored to healthcare needs across North America.
Products & Services of Covalon
Covalon offers a comprehensive portfolio of products and services, including CovaClear IV, IV Clear, VALGuard, SurgiClear, and ColActive Plus.
Transparent dressing for sensitive skin and IV protection
Dual-antimicrobial dressing for IV lines
Line guard to prevent contamination
Antimicrobial dressing for surgical sites
Collagen dressing for advanced wound healing
Apps and channels of Covalon
its YouTube channel Covalon Technologies has 401 subscribers and 14 videos.
Videos from Covalon
The most watched videos on Covalon's YouTube channel, Covalon Technologies (401 subscribers). Click a video to play it here.
More on Covalon Technologies.
Funding Insights of Covalon
- Total Rounds 4
- Last Round Post-IPO — $5.5M
- First Round $750,000
(Aug 2013)
- Investors Count 2
All 4 funding rounds of Covalon with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2019 | $5.5M | Post-IPO | – | – | – |
| Aug 2018 | $13.72M | Debt – Conventional | – | – | |
| Aug 2016 | Post-IPO | – | – | ||
| Aug 2013 | $750,000 | Post-IPO | – | – | – |
2 investors in total: 2 institutional.
Investors in Covalon
Covalon has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include HSBC and The Goldfarb.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| goldfarbcorp.com | ||||
| hsbc.ca |
Investor details for Covalon
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Covalon
47 people are tracked at Covalon (15 in leadership, 9 in board & advisors, 23 in team).
| Name | Role | Group |
|---|---|---|
Val DiTizio | Co-Founder | Leadership |
Brent Ashton | CEO | Leadership |
Jeff Cotton | Director Of Operations | Leadership |
Chrl Greg Leszczynski | Vice President, Human Resources | Leadership |
Kim Crooks | Chief Operating Officer | Leadership |
Greg Leszczynski | Vice President, Human Resources | Leadership |
Thys Muller | Vice President, US Sales And Global Marketing | Leadership |
Alyssa Hrycyshyn | VP, Marketing | Leadership |
John Wyman | Human Resources Director | Leadership |
Abin Kurian Kommattam | Director - Business Development - Middle East & APAC | Leadership |
Daniel Castillo - | International Business Development Director | Leadership |
Said Loloie | Director, Operations | Leadership |
Saleha Assadzada | Executive Assistant To The CEO | Leadership |
Katie Martinovich | Vice President, Finance / Cfo, Interim | Leadership |
Tricia Hindman Dittlau | Vice President Of Sales | Leadership |
Ian Brindle | Director | Board & advisors |
Gale Pollock | Director | Board & advisors |
Ron Smith | Director | Board & advisors |
Abe Schwartz | Chairman | Board & advisors |
Joseph Cordiano | Director | Board & advisors |
27 more people are available in the full profile.
Complete people profiles for Covalon
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Covalon
Covalon is a publicly listed company on the TSXV with ticker symbol COV in Canada, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date03 Sep 2004
- Listed onTSX-V: COV
- Listed entityCovalon Technologies Ltd.
- Exchange sectorHealth technology
- ISINCA22282D3022
- Share price4.07 CAD (+2.52% on the day) · 2026-10-13
- Market capitalisation112,405,575.00 CAD
- Price to earnings25.8
- EPS (diluted, trailing year)0.16 CAD
- Volume (last session)40,964
Financials of Covalon
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 32.8M CAD | 2.1M CAD | 2.7M CAD |
| 2024 | 31.2M CAD | 2.7M CAD | 3.1M CAD |
| 2023 | 26.6M CAD | -4.5M CAD | -3.6M CAD |
| 2022 | 18.1M CAD | -9.7M CAD | -8.1M CAD |
| 2021 | 19.6M CAD | 2.1M CAD | 736,990 CAD |
Detailed financial statements for Covalon
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Covalon
Covalon has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include AquaGuard.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Manufacturer of moisture barrier product to keep wounds, dressings and intravenous sites dry | aqua-guard.com | Kent, United States | 2004 | Sep 2018 | $12.38M |
Complete acquisition details for Covalon
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Covalon
5 dated milestones of Covalon across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Covalon is founded.
- IPO Lists on the stock exchange (IPO).
- Funding First funding round of $750K.
- Acquisition Acquires AquaGuard.
- Funding Latest funding round, Post-IPO, of $5.5M.
Web traffic of Covalon
The website of Covalon (covalon.com) receives about 3.3K visits a month.
- Monthly visits3.3K
▼ 17.3% vs previous month
Websites whose visitors overlap most with Covalon. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| dermarite.com | 100% | 9.7K | #2,476,646 | View details | |
| medicalmonks.com | 88% | #270,355 | View details | ||
freestylefitness.ca | freestylefitness.ca | 62% | – | ||
impactteam.info | impactteam.info | 62% | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Covalon
Complete news archive for Covalon
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Covalon
Covalon was founded in 2003 and raised its 1st funding round 10 years after it was founded.
Covalon is headquartered in Toronto, Canada. It is registered at Toronto, Ontario, Canada.
Brent Ashton is the CEO of Covalon, as recorded in our data.
Annual revenue of Covalon is $23.57M as on Sep 30, 2025.
Covalon Technologies was founded in 2003 in Toronto, Canada, within the medical technology sector. Advanced technologies, products, and services are created to meet requirements of medical device companies and healthcare providers. Collaboration occurs with manufacturers, leveraging a patent portfolio and in-house laboratory facilities to deliver specialized expertise and support. Operations focus on innovation tailored to healthcare needs across North America.
Covalon offers CovaClear IV, IV Clear, VALGuard, SurgiClear, and ColActive Plus.
Yes, Covalon is publicly traded on TSXV under the ticker symbol COV.
Covalon has made 1 acquisition, including AquaGuard.
Covalon has 2 investors. Key investors include HSBC, and The Goldfarb.